Information Library
Case Studies - Phase IIIB/IV
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
Coordinating Safety Across Functions and Phases
November 3, 2009
A customer faced significant challenges with clinical and post-marketing safety. Without previous drug safety experience, they needed an ally who could provide a full range of safety and risk management solutions. -
Maximizing Post-Marketing Research for Robust ROI
September 18, 2009
Quintiles leveraged its expertise and resources in a large-scale observational study to produce valuable post-marketing data for commercial success. -
Diabetes Outcomes
September 8, 2009
This Phase IIIB diabetes study involved cardiovascular outcomes assessed over 6 years. Learn how Quintiles helped the customer overcome the challenges of patient retention, data collection and evaluation. -
Post-Marketing Commitment Study
June 30, 2009
Quintiles developed creative and effective solutions to deliver quality data, cost efficiently and ahead of schedule. -
Blended Site Monitoring
March 27, 2009
Quintiles Project Coordination Centers provide centralized support to investigators and sites in collaboration with traditional on-site staff (CRAs). -
Accelerating a Trial Delayed by Slow Approvals
March 27, 2009
Intense remote monitoring by project coordination center quickly speeds up recruitment -
Antibiotic Safety Assessment
March 25, 2009
A major pharmaceutical company presented Quintiles with a pressing challenge – to collect extensive amounts of Phase IV data in compressed time windows because the treatment conditions were subject to seasonal variants.
Page 1 of 1 (7 items)